NIH-funded research U01 cooperative agreement

Not a Number Program: preventing child exploitation in Minnesota

Official title: CE22-003 - A Randomized Controlled Trial Evaluation of the Not a Number Program to Prevent the Commercial Sexual Exploitation of Children (CSEC) and Youth in Minnesota

Funded at University of New Hampshire · NIH-11407513 · Data updated 2026-11-12

A community-based program tests a prevention education plan to lower the risk of sexual exploitation among Minnesota youth.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of New Hampshire
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2027
Funding year2026
Award (this year)$397,636
NIH project number5U01CE003406-05
Project IDNIH-11407513 on NIH RePORTER

Who could benefit from this research

Could help

Youth who are at risk for commercial sexual exploitation and are served by partnering Minnesota agencies may be eligible to benefit.

Less likely to help

Youth not at risk for CSEC or not connected with participating agencies may not directly benefit.

What this research studies

This project tests whether the Not a Number (NAN) prevention education program can reduce victimization from commercial sexual exploitation among at-risk youth in Minnesota. It uses a cluster randomized design across 24 youth-serving agencies and involves a train-the-trainer model to disseminate NAN. The study follows a community-based participatory approach to understand what prevention goals communities value and to refine evaluation methods before full implementation. Over five years, researchers will assess how NAN is implemented, gather qualitative and quantitative data, and determine its effectiveness in real-world settings.

Why it matters

Potential benefit: If successful, NAN could provide communities with an evidence-based tool to prevent CSEC and protect youth from harm.

How similar studies have gone: Previous programs with prevention education show promise, but NAN specifically has not yet been evaluated in this setting, making results informative but not yet established.

Where this research is happening

  • University of New Hampshire
    Durham, United States
    Active

Researchers

  • Principal investigator: Jones, Lisa M — University of New Hampshire
  • Study coordinator: Jones, Lisa M

Related research

Other NIH-funded projects on the same topics.

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

  • Shorter antifungal course for kids with candidemia

    A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606502

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.